Source: Program and Abstract Book. Conference titles: International Cell Death Symposium on. Unidades: FCFRP, ICB
Subjects: QUIMIOTERÁPICOS, APOPTOSE, ONCOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURLAN, Renata Lígia A. et al. Cosmomycin D, an anthracycline more potent than Doxorubicin for induction of tumor cell death, synergize with imatinib mesilate to induce apoptosis in Bcr-Abl-positive cells. 2006, Anais.. Angra dos Reis: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2006. . Acesso em: 07 nov. 2025.APA
Furlan, R. L. A., Ulbrich, A., Brumatti, G., Castro, F. A. de, Garrido, L. M., Padilla, G., & Amarante-Mendes, J. G. P. (2006). Cosmomycin D, an anthracycline more potent than Doxorubicin for induction of tumor cell death, synergize with imatinib mesilate to induce apoptosis in Bcr-Abl-positive cells. In Program and Abstract Book. Angra dos Reis: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.NLM
Furlan RLA, Ulbrich A, Brumatti G, Castro FA de, Garrido LM, Padilla G, Amarante-Mendes JGP. Cosmomycin D, an anthracycline more potent than Doxorubicin for induction of tumor cell death, synergize with imatinib mesilate to induce apoptosis in Bcr-Abl-positive cells. Program and Abstract Book. 2006 ;[citado 2025 nov. 07 ]Vancouver
Furlan RLA, Ulbrich A, Brumatti G, Castro FA de, Garrido LM, Padilla G, Amarante-Mendes JGP. Cosmomycin D, an anthracycline more potent than Doxorubicin for induction of tumor cell death, synergize with imatinib mesilate to induce apoptosis in Bcr-Abl-positive cells. Program and Abstract Book. 2006 ;[citado 2025 nov. 07 ]
